SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13: 295306.
  • Aoka Y, Johnson FL, Penta K, Hirata K, Hidai C, Schatzman R, Varner JA, Quertermous T. 2002. The embryonic angiogenic factor del1 accelerates tumor growth by enhancing vascular formation. Microvasc Res 64: 148161.
  • Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. 1998. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 233240.
  • Bader BL, Rayburn H, Crowley D, Hynes RO. 1998. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95: 507519.
  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435439.
  • Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389395.
  • Davies JA. 2002. Do different branching epithelia use a conserved developmental mechanism? Bioessays 24: 937948.
  • Dunlop SA, Moore SR, Beazley LD. 1997. Changing patterns of vasculature in the developing amphibian retina. J Exp Biol 200(Pt 18): 24792492.
  • Fisher CE, Michael L, Barnett MW, Davies JA. 2001. Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. Development 128: 43294338.
  • Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA. 1996. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 93: 97649769.
  • Healy JC. 2005. Jejunum and ileum. In: StandringS, editor. Gray's anatomy. Edinburgh: Elsevier. p 11671171.
  • Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous EE, Aoka Y, Fukagawa M, Matsui Y, Platika D, Auerbach R, Hogan BL, Snodgrass R, Quertermous T. 1998. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 12: 2133.
  • Hidai C, Okada M, Ikeda H, Nagashima H, Matsuoka R, Quertermous T, Kasanuki H, Kokubun S, Kawana M. 2003. FGF-1 enhanced cardiogenesis in differentiating embryonal carcinoma cell cultures, which was opposite to the effect of FGF-2. J Mol Cell Cardiol 35: 421425.
  • Hoffman MP, Kidder BL, Steinberg ZL, Lakhani S, Ho S, Kleinman HK, Larsen M. 2002. Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms. Development 129: 57675778.
  • Hohenester E, Engel J. 2002. Domain structure and organisation in extracellular matrix proteins. Matrix Biol 21: 115128.
  • Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 19941998.
  • Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193199.
  • Peng J, Zhang L, Drysdale L, Fong GH. 2000. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA 97: 83868391.
  • Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T. 1999. Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem 274: 1110111109.
  • Peters KG. 1998. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ Res 83: 342343.
  • Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8: 2734.
  • Sakai T, Larsen M, Yamada KM. 2003. Fibronectin requirement in branching morphogenesis. Nature 423: 876881.
  • Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 7074.
  • Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 6266.
  • Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 11711180.
  • Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282: 468471.
  • Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T. 1998. The chemokine receptor CXCR-4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591594.
  • Thurston G, Murphy TJ, Baluk B, Lindsey R, McDonald DM. 1998. Angiogenesis in mice with chronic airway inflammation. Am J Pathol 153: 10991112.
  • Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741753.
  • Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407: 242248.
  • Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T, Coleman M, Boudreau N, Varner. JA. 2003. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest 112: 3041.